Grace Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CERITY PARTNERS LLC | 05/15/2026 | 849.06 K | $3.93 M | 100.85% | 5.01% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 756.60 K | $3.50 M | 100.00% | 4.47% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 728.20 K | $3.37 M | -38.19% | 4.30% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 494.72 K | $2.29 M | 0.01% | 2.92% |
| 05/15/2026 | 401.66 K | $1.86 M | 100.00% | 2.37% | |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 243.91 K | $1.13 M | 87.94% | 1.44% |
| JANE STREET GROUP, LLC | 05/12/2026 | 167.10 K | $773.66 K | 100.00% | 0.99% |
| CITADEL ADVISORS LLC | 05/15/2026 | 98.74 K | $457.18 K | 133.45% | 0.58% |
| MARSHALL WACE, LLP | 05/15/2026 | 91.42 K | $423.26 K | 100.00% | 0.54% |
| CONNECTIVE CAPITAL MANAGEMENT, LLC | 05/13/2026 | 84.55 K | $391.46 K | 100.00% | 0.50% |
| QUADRATURE CAPITAL LTD | 05/15/2026 | 66.82 K | $309.39 K | 100.00% | 0.39% |
| XTX TOPCO LTD | 05/15/2026 | 63.09 K | $292.13 K | 108.50% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 62.20 K | $287.99 K | 100.00% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 50.60 K | $234.28 K | 100.00% | 0.30% |
| BIRCHVIEW CAPITAL, LP | 05/15/2026 | 50.00 K | $231.50 K | 100.00% | 0.30% |
| DIAMETRIC CAPITAL, LP | 05/15/2026 | 39.80 K | $184.26 K | 100.00% | 0.24% |
| PALE FIRE CAPITAL SE | 05/14/2026 | 37.76 K | $174.84 K | 100.00% | 0.22% |
| UBS GROUP AG | 05/05/2026 | 26.30 K | $121.77 K | 100.00% | 0.16% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 04/20/2026 | 13.00 K | $60.19 K | 100.00% | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 10.07 K | $46.64 K | 100.00% | 0.06% |
| OPPENHEIMER & CO INC | 04/24/2026 | 10.00 K | $46.30 K | 100.00% | 0.06% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 8.75 K | $40.51 K | 100.00% | 0.05% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 7.10 K | $32.87 K | 1,083.33% | 0.04% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 5.00 K | $23.15 K | 100.00% | 0.03% |
| MORGAN STANLEY | 05/15/2026 | 4.55 K | $21.06 K | -82.13% | 0.03% |
| NATIONAL BANK OF CANADA /FI/ | 05/15/2026 | 2.72 K | $12.58 K | 0.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 1.80 K | $8.33 K | 100.00% | 0.01% |
| ROYAL BANK OF CANADA | 05/15/2026 | 543 | $3.00 K | 0.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 500 | $2.32 K | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 415 | $1.92 K | -78.66% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 04/15/2026 | 104 | $482 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 82 | $380 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 70 | $324 | -30.69% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 41 | $190 | 0.00% | 0.00% |
| NBC SECURITIES, INC. | 04/14/2026 | 2 | $9 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 1 | $5 | 0.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| STRATOS WEALTH PARTNERS, LTD. | 04/28/2026 | 0 | $0 | -100.00% | 0.00% |
| FLAGSHIP HARBOR ADVISORS, LLC | 04/28/2026 | 0 | $0 | -100.00% | 0.00% |
| AIGH CAPITAL MANAGEMENT LLC | 04/30/2026 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Grace Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 39 institutional investors and hedge funds held shares of Grace Therapeutics Inc.. The most heavily invested institutionals were:
Cerity Partners LLC: 849,055
Eversept Partners, LP: 756,600
Nantahala Capital Management, LLC: 728,203
BANK OF AMERICA CORP /DE/: 494,723
RENAISSANCE TECHNOLOGIES LLC: 243,910
JANE STREET GROUP, LLC: 167,097
25.18% of Grace Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.29 M shares in the last 24 months. This purchase volume represents approximately $16.85 M in transactions.